Skip to content

Clinical trials

Completed Bone Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Status: Completed Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20031
20041
20064
20073
20083
20091
20101
20114
20121
20133
20144
20153
20161
20173
20191
20215
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Memorial Sloan Kettering Cancer Center3
InSightec2
M.D. Anderson Cancer Center2
Stanford University2
University of Florida2
Wake Forest University Health Sciences2
Amgen1
AstraZeneca1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms50
Sarcoma22
Breast Neoplasms13
Neoplasms13
Lung Neoplasms10
Osteosarcoma10
Prostatic Neoplasms9
Multiple Myeloma8
Brain Neoplasms7
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.